EU Committee Gets Tough On Environmental Pharma Pollution
Better Controls, Lower Drug Consumption Advised
Members of the European Parliament have backed tougher measures to tackle the damage caused to the environment by pharmaceuticals, saying the approach outlined by the European Commission last year is too “soft.”
You may also be interested in...
The European Commission has outlined actions that the pharmaceutical industry and other stakeholders need to take in order to minimize the risk of pharmaceuticals contaminating the environment.
New guidance from the UK covers the recognition of EU approvals, accelerated assessment, rolling reviews, and much else besides.
As negotiations between the UK and EU enter a crucial phase, the UK life sciences industry has called for more clarity and guidance on what companies can expect to face at the end of the Brexit transition period.